Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

AI and machine learning in RNA therapeutics As we neared the end ... There are more than 100 different types of RNA modifications, but these need to be precisely placed to maximise their impact.

Such modifications have some very important ... could therefore provide new directions for the development of RNA-based therapeutics" says Höbartner. "It is conceivable that further developed ...

Such modifications have some very important ... could therefore provide new directions for the development of RNA-based therapeutics" says Höbartner. "It is conceivable that further developed ...

Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlex™ platform, the first to concurrently detect and quantify multiple RNA ...

Atalanta Therapeutics has technology that delivers RNA interference therapies into the CNS. The startup has spent the past four years quietly working on its technology and potential drugs.

SMi’s 11 th annual RNA Therapeutics conference, taking place on 19 th – 20 th February in London, will bring together industry experts from leading RNA therapeutics companies to discuss the ...

This is where RNA-based therapies are poised to make a significant impact. RNA-based precision therapeutics are emerging as a game-changer for genetic disorders, including IRDs. Unlike DNA or ...